UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association of blood group with COVID‐19 disease susceptibility and severity in Saudi Arabia

Transfusion (Philadelphia, Pa.), 2023-02, Vol.63 (S1), p.S3-S9

2023

Volltextzugriff (PDF)

Low clinical utility of testing for anti‐platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV‐19 vaccine

International journal of laboratory hematology, 2022-04, Vol.44 (2), p.424-429

2022

Volltextzugriff (PDF)

Genetic Patterns of Oral Cavity Microbiome in Patients with Sickle Cell Disease

International journal of molecular sciences, 2024-08, Vol.25 (16), p.8570

2024

Volltextzugriff (PDF)

Profiling of microRNAs by next-generation sequencing: Potential biomarkers for diffuse large B-cell lymphoma

Journal of Taibah University Medical Sciences, 2024-06, Vol.19 (3), p.619-627

2024

Volltextzugriff (PDF)

Absolute Thrombocytopenia with Ticagrelor

Journal of applied hematology, 2024-01, Vol.15 (1), p.82-85

2024

Volltextzugriff (PDF)

A Saudi multicenter experience on therapeutic plasma exchange for patients with thrombotic thrombocytopenic purpura: A call for national registry

Journal of clinical apheresis, 2023-10, Vol.38 (5), p.573-581

2023

Volltextzugriff (PDF)

Acute Myeloid Leukemia with Acute Spinal Cord Compression as the First Feature

Journal of applied hematology, 2023-10, Vol.14 (4), p.327-330

2023

Volltextzugriff (PDF)

The wizard of artificial intelligence: Are physicians prepared?

Journal of family and community medicine, 2024-10, Vol.31 (4), p.344-350

2024

Volltextzugriff (PDF)

Blastocystis sp.—An emerging cause of diarrhea post stem cell transplantation

Clinical case reports, 2023-05, Vol.11 (5), p.e7285-n/a

2023

Volltextzugriff (PDF)

Outcomes of Cholelithiasis Among Patients With Sickle Cell Disease: A Tertiary Care Center Experience

Curēus (Palo Alto, CA), 2023-03

2023

Volltextzugriff (PDF)

Antiphospholipid Antibody Testing: An Audit on Testing Practices in a Public Tertiary Care Center

Journal of clinical medicine, 2023-12, Vol.13 (1), p.243

2023

Volltextzugriff (PDF)

Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies

Vaccines (Basel), 2022-01, Vol.10 (2), p.151

2022

Volltextzugriff (PDF)

Quality of Systematic Reviews/Meta-Analyses in Coronavirus Disease 2019 and Venous Thromboembolism: An Analysis using a Measurement Tool to Assess Systematic Reviews-2

Journal of Applied Hematology, 2022-10, Vol.13 (4), p.222-227

2022

Volltextzugriff (PDF)

Attitude of Previous Blood Donors toward Blood Donation during COVID-19

Journal of applied hematology, 2023-10, Vol.14 (4), p.300-309

2023

Volltextzugriff (PDF)

Predisposing Factors and Incidence of Venous Thromboembolism among Hospitalized Patients with Sickle Cell Disease

Journal of clinical medicine, 2023-10, Vol.12 (20), p.6498

2023

Volltextzugriff (PDF)

The Prevalence of Depression and Anxiety Among Sickle Cell Disease Patients in King Abdulaziz University Hospital

Curēus (Palo Alto, CA), 2021-09

2021

Volltextzugriff (PDF)

Association of Genetic Variant FVIII Gene and Factor VIII: A Pilot Study Among Hemophilia A Female Relatives in Saudi Arabia

Curēus (Palo Alto, CA), 2023-07

2023

Volltextzugriff (PDF)

Primary Central Nervous System Burkitt Lymphoma, Presenting with Long-Term Fluctuating Level of Consciousness: A Case Report and Literature Review on Challenges in Diagnosis and Management

The American journal of case reports, 2022-06, Vol.23, p.e936401-e936401

2022

Volltextzugriff (PDF)

Outcomes of therapeutic plasma exchange: A 15-year tertiary center experience

Iraqi Journal of Hematology, 2023, Vol.12 (1), p.20

2023

Volltextzugriff (PDF)

Unusual Presentation of Leukemic-Phase Mantle Cell Lymphoma: A Case Report

Curēus (Palo Alto, CA), 2023-01

2023

Volltextzugriff (PDF)

COVID‐19‐induced immune thrombocytopenia management approach: A case report and literature review

Clinical case reports, 2024-06, Vol.12 (6), p.e9070-n/a

2024

Volltextzugriff (PDF)

Does Upfront Autologous Stem Cell Transplant at First Relapse Improve Outcome in Transplant Eligible Follicular Lymphoma Patients Who Relapse within 24 Months

Blood, 2020-11, Vol.136 (Supplement 1), p.41-41

2020

Volltextzugriff (PDF)

Does Lymphocyte Count Impact Dosing of Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplantation?

Biology of blood and marrow transplantation, 2020-07, Vol.26 (7), p.1298-1302

2020

Volltextzugriff (PDF)

Does Up-front Autologous Stem-Cell Transplantation at First Relapse Improve Outcome in Transplant-Eligible Follicular Lymphoma Patients Whose Disease Relapses Within 24 Months?

Clinical lymphoma, myeloma and leukemia, 2021-04, Vol.21 (4), p.e423-e427

2021

Volltextzugriff (PDF)

A Strategy of Day 14 Bone Marrows and Early Intervention Is Associated with Similar Outcomes Compared to a Strategy of No Day 14 Bone Marrows and Delayed Intervention in Patients with Acute Myeloid Leukemia

Blood, 2017-12, Vol.130, p.2584-2584

2017

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(34)
Buchkapitel
(1)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Association of blood group with COVID‐19 disease susceptibility and severity in Saudi Arabia

Low clinical utility of testing for anti‐platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV‐19 vaccine

Genetic Patterns of Oral Cavity Microbiome in Patients with Sickle Cell Disease

Profiling of microRNAs by next-generation sequencing: Potential biomarkers for diffuse large B-cell lymphoma

Absolute Thrombocytopenia with Ticagrelor

A Saudi multicenter experience on therapeutic plasma exchange for patients with thrombotic thrombocytopenic purpura: A call for national registry

Acute Myeloid Leukemia with Acute Spinal Cord Compression as the First Feature

The wizard of artificial intelligence: Are physicians prepared?

Blastocystis sp.—An emerging cause of diarrhea post stem cell transplantation

Outcomes of Cholelithiasis Among Patients With Sickle Cell Disease: A Tertiary Care Center Experience

Antiphospholipid Antibody Testing: An Audit on Testing Practices in a Public Tertiary Care Center

Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies

Quality of Systematic Reviews/Meta-Analyses in Coronavirus Disease 2019 and Venous Thromboembolism: An Analysis using a Measurement Tool to Assess Systematic Reviews-2

Attitude of Previous Blood Donors toward Blood Donation during COVID-19

Predisposing Factors and Incidence of Venous Thromboembolism among Hospitalized Patients with Sickle Cell Disease

The Prevalence of Depression and Anxiety Among Sickle Cell Disease Patients in King Abdulaziz University Hospital

Association of Genetic Variant FVIII Gene and Factor VIII: A Pilot Study Among Hemophilia A Female Relatives in Saudi Arabia

Primary Central Nervous System Burkitt Lymphoma, Presenting with Long-Term Fluctuating Level of Consciousness: A Case Report and Literature Review on Challenges in Diagnosis and Management

Outcomes of therapeutic plasma exchange: A 15-year tertiary center experience

Unusual Presentation of Leukemic-Phase Mantle Cell Lymphoma: A Case Report

COVID‐19‐induced immune thrombocytopenia management approach: A case report and literature review

Does Upfront Autologous Stem Cell Transplant at First Relapse Improve Outcome in Transplant Eligible Follicular Lymphoma Patients Who Relapse within 24 Months

Does Lymphocyte Count Impact Dosing of Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplantation?

Does Up-front Autologous Stem-Cell Transplantation at First Relapse Improve Outcome in Transplant-Eligible Follicular Lymphoma Patients Whose Disease Relapses Within 24 Months?

A Strategy of Day 14 Bone Marrows and Early Intervention Is Associated with Similar Outcomes Compared to a Strategy of No Day 14 Bone Marrows and Delayed Intervention in Patients with Acute Myeloid Leukemia

Suchergebnisse filtern